ASA. M. W. Spijkerman

A. M. W. Spijkerman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. M. W. Spijkerman has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 March 2008
      • Vol. 66  (3) , 110-7

    Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study.

    by R M A Henry, W J Paulus, O Kamp, P J Kostense, A M W Spijkerman, J M Dekker, G Nijpels, R J Heine, L M Bouter, C D A Stehouwer

    Type 2 diabetes (DM2) is associated with a greater risk of heart failure. The mechanisms underlying this association remain controversial and include diabetes-associated hypertension and obesity, impaired small and large artery function, and a distinct metabolic cardiomyopathy related to hyperglycaemia/ hyperinsulinaemia. The proximate causes of heart failure are left ventricular (LV) systolic dysfunction (SDF) and diastolic dysfunction (DDF). We investigated, in a population-based cohort (n=746), the association between glucose tolerance status and SDF and DDF . The study population consisted of 274 individuals with normal glucose metabolism (NGM), 174 with impaired glucose metabolism (IGM) and 298 with DM2 (mean age 68.5 years). All participants underwent an LV echocardiogram. SDF was defined as ejection fraction or =97 cm/s), the difference between Apv and Amv duration (> or =41 ms), and left atrial volume (> or =57 ml), where cut-off values were based upon the 90th percentile in NGM. In addition, we analysed the ratio of early to late diastolic filling (E/A ratio) on a continuous scale using linear regression analyses. The age- and sex-standardised prevalences in NGM, IGM and DM2 were 13, 14 and 30% for SDF , and 26, 36 and 47% for DDF (P trend for both <0.001). After adjustment for sex, age, hypertension, body mass index, prior cardiovascular disease and (micro) albuminuria, DM2 was significantly associated with both SDF (odds ratio (95% CI) 2.04 (1.24 to 3.36)) and DDF (2.42 (1.63 to 3.60)) (90th percentile definition). This was also true for the analyses with the E/A ratio on a continuous scale (regression coefficient b (95% CI) -0.05 (-0.09 to -0.01). After adjustment for sex, age, hypertension, body mass index, prior cardiovascular disease and (micro) albuminuria IGM was not significantly associated with SDF (odds ratio (95% CI) 1.04 (0.58 to 1.88)) or DDF (1.33 (0.86 to 2.06)) using the definition based upon the 90th percentile. However, IGM was significantly associated with DDF if the E/A ratio was analysed on a continuous scale (regression coefficient beta (95% CI) -0.05 (-0.10 to -0.01). Additional adjustment for brachial artery flow-mediated vasodilation or arterial stiffness, as measures of large artery function, did not materially alter the results. Hyperglycaemia and hyperinsulinaemia together explained approximately 30% of the association of DM2 with SDF and approximately 40% of that with DDF . DM2 is independently associated with a 2.0-fold greater risk of SDF and a 2.4-fold greater risk of DDF . IGM was not associated with SDF , and the association with DDF was limited to the E/A ratio. These observations may therefore explain the increased risk of systolic and diastolic heart failure in elderly individuals with DM2.


  • Endothelial dysfunction and low‐grade inflammation and the progression of retinopathy in Type 2 diabetes

    by A. M. W. Spijkerman, M.‐A. Gall, L. Tarnow, J. W. R. Twisk, E. Lauritzen, H. Lund‐Andersen, J. Emeis, H.‐H. Parving, C. D. A. Stehouwer

    Aims  To study whether microalbuminuria, endothelial dysfunction and low‐grade inflammation are associated with the presence and progression of diabetic retinopathy.Methods  Patients with Type 2 diabetes (n = 328) attending a diabetes clinic were followed for 10 years and examined annually during the last 7 years. Retinopathy was assessed after pupillary dilatation by direct ophthalmoscopy (baseline) and two‐field 60° fundus photography (follow‐up). Urinary albumin excretion, and markers of endothelial function (von Willebrand factor, tissue‐type plasminogen activator, soluble E‐selectin (sE‐selectin), and soluble vascular cell adhesion molecule 1) and inflammatory activity (C‐reactive protein and fibrinogen) were determined.Results  The prevalence of retinopathy was 33.8%. The median diabetes duration at baseline was 7 years (interquartile range 2–12 years). The highest tertiles of baseline urinary albumin excretion and glycated haemoglobin (HbA1c) were associated with prevalent retinopathy: odds ratio (OR) 95% confidence interval (CI) 2.80 (1.44–5.46) and 2.19 (1.11–4.32), respectively. Progression of retinopathy occurred in 188 patients. The second and third tertiles of baseline sE‐selectin were associated with progression of retinopathy [1.44 (1.04–2.01) and 1.61 (1.19–2.18)] but not independently of HbA1c. None of the other markers was significantly associated with the presence or progression of retinopathy. High baseline HbA1c was significantly associated with progression of retinopathy: 1.65 (1.21–2.25).Conclusions  In this population of patients with Type 2 diabetes who attended a diabetes clinic, there was some evidence for a role of endothelial dysfunction in the progression of retinopathy. We could not demonstrate a role for low‐grade inflammation. Our study emphasizes the importance of glycaemic control in the development and progression of retinopathy.


  • Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study

    by A. M. W. Spijkerman, R. M. A. Henry, J. M. Dekker, G. Nijpels, P. J. Kostense, J. A. Kors, D. Ruwaard, C. D. A. Stehouwer, L. M. Bouter, R. J. Heine

    : Objectives.  Screening for type 2 diabetes has been recommended and targeted screening might be an efficient way to screen. The aim was to investigate whether diabetic patients identified by a targeted screening procedure differ from newly diagnosed diabetic patients in general practice with regard to the prevalence of macrovascular complications.Design.  Cross‐sectional population‐based study.Setting.  Population study, primary care.Subjects.  Diabetic patients identified by a population‐based targeted screening procedure (SDM patients), consisting of a screening questionnaire and a fasting capillary glucose measurement followed by diagnostic testing, were compared with newly diagnosed diabetic patients in general practice (GPDM patients). Ischaemic heart disease and prior myocardial infarction were assessed by ECG recording. Peripheral arterial disease was assessed by the ankle‐arm index. Intima‐media thickness of the right common carotid artery was measured with ultrasound.Results.  A total of 195 SDM patients and 60 GPDM patients participated in the medical examination. The prevalence of MI was 13.3% (95% CI 9.3–18.8%) and 3.4% (1.0–11.7%) in SDM patients and GPDM patients respectively. The prevalence of ischaemic heart disease was 39.5% (95% CI 32.9–46.5%) in SDM patients and 24.1% (15.0–36.5%) in GPDM patients. The prevalence of peripheral arterial disease was similar in both groups: 10.6% (95% CI 6.9–15.9%) and 10.2% (4.7–20.5%) respectively. Mean intima‐media thickness was 0.85 mm (±0.17) in SDM patients and 0.90 mm (±0.20) in GPDM patients. The difference in intima‐media thickness was not statistically significant.Conclusions.  Targeted screening identified patients with a prevalence of macrovascular complications similar to that of patients detected in general practice, but with a lower degree of hyperglycaemia.